Objective: A randomized controlled trial was conducted to clarify the effectiveness of intraoperative blood salvage in reducing blood loss. Background: Although reduction of central venous pressure (CVP) is thought to decrease blood loss during liver resection, no consistently effective and safe method for obtaining the desired reduction of CVP has been established. Methods: Living liver donors scheduled to undergo liver graft procurement were randomly assigned to a blood salvage group, in which a blood volume equal to approximately 0.7% of the patient's body weight was collected before the liver transection, or a control group. The surgeons were blinded to the randomization results. The primary outcome measure was blood loss during liver parenchymal division. A multivariate analysis was also performed. Results: Seventy-nine donors were allocated intraoperatively to the blood salvage group (n ϭ 40) or the control group (n ϭ 39). The amount of blood loss during liver transection was significantly smaller in the blood salvage group than in the control group (median loss during transection, 140 mL vs. 230 mL, P ϭ 0.034). The CVP at the beginning of the liver parenchymal division was significantly lower in the blood salvage group than in the control group (median, 5 cm H 2 O vs. 6 cm H 2 O, P ϭ 0.005). The results of a multivariate analysis revealed that intraoperative blood salvage offered the advantage of reduced blood loss during liver parenchymal division (adjusted OR, 0.31; 95% CI, 0.11-0.85, P ϭ 0.025).
A mbroise Pare was the first to describe the liver as the "work house of blood" in the early 16th century, and truly, control of bleeding during liver resection has been an ongoing battle for liver surgeons and anesthesiologists. Until now, the hepatic inflow occlusion technique introduced by Pringle 1 and selective and/or intermittent inflow occlusion 2 have been the most effective procedures for reducing intraoperative bleeding during hepatic resection. Reduction of intraoperative blood loss using these techniques is so dramatic that randomized trials are considered unnecessary. 3 The main source of bleeding during Pringle maneuver is the hepatic veins and their tributaries, hence, reduction of the central venous pressure (CVP), has been employed successfully to reduce intraoperative blood loss. 4 Administration of vasodilators, 5, 6 reduction of respiratory tidal volume, 7 restriction of intravenous fluid infusion, 8, 9 and clamping of the infrahepatic vena cava 10 are some of the methods that have been used to reduce CVP. However, a consistently effective and safe method to obtain the desired reduction of CVP to reduce intraoperative blood loss has not yet been established.
The authors routinely restrict fluids, reduce tidal volume, and administer a sufficient amount of muscle relaxant to mildly reduce the CVP during hepatic resection. 7 However, the amount of back bleeding remains unpredictable, and severe and unexpected back bleeding is sometimes encountered. As a preliminary investigation, we examined the effect of collection of a modest amount of blood as blood salvage after the initiation of liver transection and observed an apparent decrease in intratransectional bleeding in most of the cases.
Therefore, we were prompted to hypothesize that blood salvage before the initiation of liver parenchymal division would reduce intratransectional blood loss, and we conducted this randomized controlled trial to test this hypothesis. We chose donors for living donor liver transplantation as the subjects of the present study for the following reasons: 1) the operative procedures consist of the standard major hepatec-tomies, including right hepatectomy, left hepatectomy, and right lateral sectorectomy 11 (procurement of segment 6 and 7); 2) the donors are healthy and have normal livers, with minimal variations of liver function, including the coagulation profile, and systemic circulation; and 3) the donors stand to benefit the most from a reduction of blood loss because allogeneic blood transfusion can then be avoided.
METHODS

Eligibility Criteria
All donors scheduled to undergo liver graft procurement for elective LDLT at the Tokyo University Hospital were considered as potential participants in this trial. The inclusion criteria were as follows: acceptable general condition of the liver donor candidate, 12 and age between 18 and 65 years. The exclusion criteria were: hypertension or hypotension, hemoglobin Ͻ11 g/dL within a week prior to the operation, prothrombin time international normalization ratio Ͼ1.5, bleeding time Ͼ5 minutes, and unstable hemodynamics during surgery.
Study Design
The study was conducted after the protocol was approved by the institutional review board of Tokyo University Hospital. An English summary of the protocol (registration number; R000000029) was submitted to the Clinical Trials Registry managed by the University Hospital Medical Information Network in Japan, and can be accessed commissionfree on the Internet. (http://www.umin.ac.jp/ctr/index.htm). Written informed consent was obtained from all participants.
The participants were randomly assigned in the operating room to either the blood salvage group (BS group) or a control group using a minimization method with 3 stratifying factors: age (18 -40 years vs. 41-65 years), type of liver graft (left-sided or right-sided), and presence or absence of preoperative autologous blood donation (ABD). Preoperative ABD was performed during an elective period. The amount of banked whole blood and banked frozen plasma were no greater than 1000 mL and 1500 mL, respectively. 10 The assignments were made by an Internet-accessed randomization system administered by the University Hospital Medical Information Network in Japan, an independent randomization service. All procedures regarding the allocation, enrollment, assignment, and announcement of the assignment results to the anesthesiologists were performed by 2 investigators (T.H., Y.S.) who functioned independently of the surgical team and the donor follow-up. The surgeons were blinded to the results of the subject randomization process. In the BS group, a volume of whole blood corresponding to approximately 0.7% of the subject's body weight was withdrawn before the start of hepatic parenchymal division and stored in a specially designed bag for ABD (Terumo Blood Bag CPDA; Terumo Co., Tokyo, Japan). This modest amount of blood to be collected (0.7% of the body weight) roughly corresponded to the capacity of our blood collection bag, and our preliminary experience has revealed that withdrawal of this amount of blood is safe. The collected blood was reinfused into the patient after the graft procurement. Intraoper-ative and postoperative data were collected by 2 investigators (T.H., Y.S.), and the surgical team and participants were blinded to the data throughout the study period.
Surgical Procedures
The transplantation procedure, donor selection criteria, and surgical techniques used in this study have been described elsewhere. [11] [12] [13] [14] According to a previously established algorithm, 14 the left hemiliver with or the without the caudate lobe was selected as a left-sided graft, and the right hemiliver with or without the middle hepatic vein and right lateral sector was selected as a right-sided graft. Two surgeons (M.M., N.K.) performed all the donor operations. The liver parenchyma was divided by electrocautery using an ultrasonic dissector (SONOP 5000; Aloka Inc., Tokyo, Japan) while employing the Pringle maneuver 1,15 (10 minutes' preconditioning, 5 minutes' reperfusion, and several cycles of 15 minutes' clamping, and 5 minutes' release). 15 For right lateral sector graft procurement, the hemihepatic vascular occlusion technique was used. 2 Anesthesia was induced and maintained according to a previously described method. 7 Continuous invasive arterial pressure, heart rate, electrocardiographic, CVP, pulse oximetry, end-tidal carbon dioxide tension, and rectal temperature monitoring were conducted. Crystalloid infusion was kept at the minimum (4 -4.5 mL/kg/h). Autologous fresh frozen plasma and whole blood stored priori were transfused as necessary and to maintain stable hemodynamics during the hepatic parenchymal division. Autologous fresh frozen plasma was preferentially used to restrict the amount of infusion. In general, the remainder of the banked fresh frozen plasma was transfused within 24 hours.
Outcome Measures
The primary outcome measure was blood loss during hepatic parenchymal division. Secondary outcome measures consisted of total blood loss, blood loss during hepatic parenchymal division per unit transectional area, CVP at the start of the hepatic parenchymal division, serum aspartate aminotransferase and total bilirubin levels on the third postoperative day, length of hospital stay, and morbidity. Cumulative blood loss at the start of the parenchymal division, at the time of procurement of the liver graft, and at the time of completion of the operation was measured. The transectional area was measured using the method described in our previous study. 7, 16, 17 Briefly, an outline of the liver's cut surface was drawn on paper, and the transectional area was calculated by scanning the outlined area using Adobe Photoshop 7.0 (Adobe Systems, San Jose, CA). Complications requiring surgical or other interventions were defined as major complications, while those that resolved with conservative treatment but prolonged the hospital stay by more than 2 weeks (eg, wound infection, ileus, and minor bile leakage) were defined as minor complications.
Statistical Analyses
Among the 56 donors who underwent liver graft procurement between November 2001 and March 2003, the mean amount of blood loss during the liver parenchymal division was 282 mL (SD, 155 mL). We hypothesized that Annals of Surgery • Volume 245, Number 5, May 2007 Intraoperative Blood Salvage During Liver Resection intraoperative blood salvage decreased the amount of blood loss by 100 mL, corresponding to a 30% difference. To detect significant differences with a two-tailed type 1 error of 5% and a statistical power of 80%, 40 patients were required in each group. Background characteristics and surgical outcome measures were compared using Fisher exact test for categorized data and Wilcoxon rank sum test for continuous data. A multivariate analysis was performed using a logistic regression model to estimate the effect of intraoperative blood salvage on the amount of blood loss during liver parenchymal division, which was categorized according to a clinically relevant cutoff point (Ͻ200 mL vs. Ն200 mL). The analysis was controlled for 6 potential confounders: age (18 -39 years vs. 40 -65 years), type of liver graft (left-sided vs. rightsided), presence vs. absence of preoperative ABD, CVP at the start of liver parenchymal division (Յ5 cm H 2 O vs. Ͼ5 cm H 2 O), transection area (Ͻ65 cm 2 vs. Ն65 cm 2 ), and the hemoglobin level at the beginning of the operation (Ͻ12 g/dL vs. Ն12 g/dL). The results were expressed as the odds ratios (ORs) with 95% confidence intervals (CIs) and P values from the likelihood ratio test.
All analyses were performed on an intention-to-treat basis. A two-tailed P value of less than 0.05 was considered as statistically significant. All statistical calculations were performed using a statistical software package (JMP 5.1; SAS, Cary, NC).
RESULTS
Between December 2003 and March 2006, 102 donors electively underwent liver graft procurement. Of these, 22 were excluded from this study because of: refusal to participate (17 cases), hemoglobin level Ͻ11 g/dL (3 cases), younger than 18 years (1 case), and unacceptable coagulation profile (1 case). The remaining 80 donors were assigned to either the BS or the control group (40 in each group). One donor from the control group was later excluded from the study because of a severe asthma attack soon after the assignment and consequent cancellation of the liver graft procurement. Conse-quently, 79 donors were analyzed (Fig. 1) . The background characteristics of the 2 groups were similar, as were the operative procedures used (Tables 1, 2 ). The median amount of intraoperative blood salvage among the 40 donors in the BS group was 420 g (range, 260 -620 g). Twenty-nine donors in the BS group and 23 donors in the control group required autologous fresh frozen plasma transfusion intraoperatively. Of these, 9 in the BS group and 3 in the control group received 1 unit of banked autologous whole blood intraoperatively (P ϭ 0.115). The median volume of transfused blood (fresh frozen plasma plus whole blood) in the BS group was 900 mL (range, 400 -1900 mL) and that in the control group was also 900 mL (range, 300 -900 mL) (P ϭ 0.8369).
The intraoperative data are shown in Table 3 . Blood loss during hepatic parenchymal division was significantly lower in the BS group than in the control group (median, 140 mL; range, 40 -430 mL; vs. 230 mL; range, 40 -660 mL, respectively; P ϭ 0.034). Blood loss per unit transectional area during hepatic parenchymal division was also signifi- cantly lower in the BS group than in the control group (2.15 mL/cm 2 ; range, 0.86 -7.37 mL/cm 2 ; vs. 3.75 mL/cm 2 ; range, 0.64 -7.93 mL/cm 2 , respectively; P ϭ 0.012). Total blood loss was also smaller in the BS group than in the control group, although the difference did not reach statistical significance. The intraoperative hemodynamics were stable in all the BS group subjects. Among the intraoperative hemodynamic variables, only the CVP at the start of the liver parenchymal division differed significantly between the 2 groups; the CVP was slightly, but significantly, lower in the BS group than in the control group ( The postoperative course was similar in the 2 groups (Table 4 ). No complications related to the blood salvage were encountered in the BS group. Among the 79 donors, 3 developed major complications requiring surgical intervention: 1 patient from the BS group developed a duodenal perforation from a peptic ulcer, 1 patient from the control group suffered a major bile leakage, and 1 patient from the control group developed postoperative bleeding from the stump of the middle hepatic artery. The incidence of minor complications was similar between the 2 groups ( Table 4 ).
The results of a multivariate analysis revealed that intraoperative blood salvage offered an advantage in terms of the reduction of blood loss during liver parenchymal division (adjusted OR, 0.31; 95% CI, 0.11-0.85; P ϭ 0.025). This advantage was not influenced by any of the other parameters 
DISCUSSION
The present randomized controlled trial clearly demonstrated that intraoperative blood salvage is effective for reducing blood loss during hepatic parenchymal transection. In addition, no adverse effects associated with the intraoperative blood salvage were encountered. Although the subjects were limited to those in good health and undergoing specific surgical procedures, intraoperative blood salvage decreased the CVP level without producing any adverse hemodynamic changes, thereby allowing safe reduction of blood loss during hepatic resection.
A lower CVP level is well known to be related to reduced blood loss during liver surgery 5, 6, 8, 9 ; however, practical and feasible measures for safely reducing blood loss have not yet been reported. In 1998, Jones et al demonstrated that patients with a low CVP (Յ5 cm H 2 O) had significantly lower blood loss during hepatic resection. 4 Although their study design was prospective, the CVP in each patient was reduced by chance, and not by intention. Until now, only a few randomized controlled trials concerning the relationship between CVP and blood loss during liver resection have been reported. Wang et al conducted a prospective randomized trial using a combination of the Trendelenburg (head-down) position and the administration of dopamine, nitroglycerine, and furosemide to reduce the CVP. 18 Although the amount of blood loss during the operation and during parenchymal division was significantly smaller in the low CVP group, the CVP in the control group and the changes in the CVP in the low CVP group were not fully monitored. In contrast, several randomized trials have been reported in which an intervention successfully reduced the CVP but did not significantly reduce the blood loss. For example, Kubota et al achieved significant reduction of the CVP during liver resection by clamping the infrahepatic vena cava; however, they failed to show any significant reduction in the intraoperative blood loss during liver resection. 10 We used blood loss during hepatic parenchymal transection, not total blood loss, as the primary end point of this study because the former measure is more directly connected to the safety of the surgical and anesthesiologic procedures. When bleeding from the division plane is profound, liver transection itself can become technically difficult, possibly jeopardizing the safety of the procedure. Bleeding from the bottom of a deep operative field, such as from the root of the hepatic veins near the inferior vena cava, might even be catastrophic. The present procedure significantly contributed to increasing the safety of the operation in that it significantly reduced the blood loss during the parenchymal division. However, the improved safety may not be necessarily related to the duration of the operation; the duration of the surgery was similar in the 2 groups.
The blood loss during the operative procedures that preceded and followed the hepatic transection was not negligible, and the findings in this study were similar to those in our recently published study concerning blood loss during hepatectomy (no donors were included), in which the total intraoperative blood loss minus the blood loss during the hepatic division ranged from 200 to 300 mL. 17 The total blood loss during liver procurement for transplantation consists of, besides the blood loss during the liver transection, the bleeding related to laparotomy, thoracotomy, hilar dissection, mobilization of the hemiliver, the lymphatic discharge, and the bile discharge from the opened bile duct.
When performed preoperatively, ABD reduces the need for allogeneic blood transfusion but does not contribute to reduction of the intraoperative blood loss. Preoperative ABD has been successfully performed in patients undergoing elective liver resection for malignancies 19 and donor hepatectomies. 12,13,20 -22 Itamoto et al investigated 206 consecutive patients undergoing a hepatectomy for hepatocellular carcinoma to evaluate the necessity of preoperative ABD. 23 Their logistic regression analysis showed that a low CVP and a short operative time were correlated with lower blood loss, but the addition of preoperative ABD was not a significant factor. The total volume of autologous blood transfused (fresh frozen plasma plus whole blood) was similar in the 2 groups. Although autologous whole blood tended to be used in the donors from whom relatively small amounts of fresh frozen plasma were prepared, the increased need for autologous blood transfusion was not directly related to the blood salvage itself.
Normovolemic hemodilution is another option that has been reported to be effective for avoiding allogeneic blood transfusion in cases undergoing liver resection. 24 This technique entails the removal of blood from the patient immediately before the operation and simultaneous replacement of the removed blood with an appropriate volume of crystalloid or colloid fluids. One randomized trial in patients undergoing major liver resection revealed that this technique had a beneficial effect in terms of the avoidance of allogeneic blood transfusion, but not in terms of blood loss. 25 However, the intraoperative blood salvage procedure used in the present study differs from the normovolemic hemodilution technique in that the intravascular volume is not replaced. In addition, the volume of the removed blood in the aforementioned normovolemic hemodilution study was 2020 Ϯ 412 mL, or about 5 times greater than that withdrawn in our study (420 g). Intraoperative blood salvage can be regarded as an acute reduction of the net circulating volume sufficient to produce a mild and safe decrease in the CVP, allowing a significant reduction of bleeding from the plane of division of the liver.
One of the possible adverse effects of intraoperative blood salvage is hypotension resulting from insufficient intravascular volume replacement. Prior to the current study, we safely performed intraoperative blood salvage in 7 live donors undergoing emergent procedures, in whom preoperative ABD was not feasible. The anesthesiologists collected about 300 to 500 mL of blood from the patients; all of the stored blood was reinfused after the hepatic transection. The hemodynamics of the donors were carefully monitored during the operations. In each case, the patient's hemodynamics remained stable and no adverse effects resulting from the blood salvage occurred, possibly because the volume of the blood withdrawn was relatively small.
Care must be exercised in expanding the indications of intraoperative blood salvage to other situations because the subjects of this trial were limited to those in good health and with normal liver function. Nonetheless, in patients with metastatic liver tumors, this method would be well adopted. On the other hand, caution should be exercised in patients with hepatocellular carcinoma because most of these patients have impaired liver function. The safety of intraoperative blood salvage should be studied further in such patients before extrapolating the results of this study to these cases.
CONCLUSION
Moderate intraoperative blood salvage safely and significantly reduced blood loss at the time of hepatic parenchymal division during liver graft procurement. This intervention can be readily performed as long as an ABD bag is available. The reduction in bleeding during liver surgery enabled by intraoperative blood salvage would increase the safety margin not only for living liver donors, but also for other patients with hepatic tumors.
